Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Semina ciênc. agrar ; 42(05): 2959-2977, set.-out. 2021. ilus, tab, graf
Artículo en Inglés | VETINDEX | ID: biblio-1501884

RESUMEN

The study aimed to evaluate the in vitro antioxidant action of glycosaminoglycans (GAGs) from the skinof Oreochromis niloticus, and to determine their ideal concentration to supplement the sperm freezing medium of Prochilodus brevis. In experiment 1, the in vitro antioxidant properties of GAGs were verified through the analysis of DPPH, chelating ferrous ability, and total antioxidant capacity. In experiment 2, milt pools were formed, which were frozen in solution supplemented or not with different GAGs concentrations: 0 (control), 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, or 5.0 mg mL-¹ (total of 10 treatments). The samples were evaluated for membrane integrity, DNA integrity, sperm morphology, and sperm kinetics. The results of experiment 1 showed that the GAGs exhibited, with the increase of the concentration, significant antioxidant action, for all the evaluated tests, mainly in the chelating ferrous ability. In experiment 2, it was observed that the increase of GAGs concentration decreased kinetic parameters (P < 0.05), however, the control and 0.5 mg mL-1 GAGs concentration showed similar results. For the other parameters (membrane integrity, DNA integrity, and sperm morphology), there was no decrease in results with the increase of GAGs concentration. In conclusion, GAGs extracted from O. niloticus skin have antioxidant action, and the concentration of 0.5 mg mL-¹ was the most adequate to supplement the P. brevis sperm-freezing medium.


O estudo teve como objetivo avaliar in vitro a ação antioxidante de glicosaminoglicanos (GAGs) da pele de Oreochromis niloticus e determinar sua concentração ideal para suplementar o meio de congelação espermático de Prochilodus brevis. No experimento 1, foram verificadas as propriedades antioxidantes in vitro dos GAGs por meio das análises de DPPH, capacidade quelante do ferro e capacidade antioxidante total. No experimento 2, foram formados pool de sêmen, que foram congelados em solução suplementada, ou não, com diferentes concentrações de GAGs: 0 (controle); 0,5; 1,0; 1,5; 2,0; 2,5; 3,0; 3,5; 4,0; 4,5 ou5,0 mg mL-¹ (total de 10 tratamentos). As amostras foram avaliadas quanto à integridade da membrana, integridade do DNA, morfologia e cinética espermática. Os resultados do experimento 1, mostraram que os GAGs exibiram, com o aumento da concentração, ação antioxidante significativa, para todos os testes avaliados, principalmente na capacidade quelante do ferro. No experimento 2, observou-se que o aumento da concentração de GAGs diminuiu os parâmetros cinéticos (P < 0,05), porém o controle e a concentração de 0,5 mg mL-1 de GAGs apresentaram resultados semelhantes. Para os demais parâmetros (morfologia, integridade de membrana e de DNA), não houve diminuição dos resultados com o aumento da concentração de GAGs. Em conclusão, os GAGs, extraídos da pele de O. niloticus, possuem ação antioxidante, sendo a concentração de 0,5 mg mL-1 a mais adequada para suplementar o meio de congelação espermático de P. brevis.


Asunto(s)
Masculino , Animales , Antioxidantes/análisis , Characiformes/genética , Cíclidos/fisiología , Criopreservación/métodos , Criopreservación/veterinaria , Glicosaminoglicanos/análisis , Glicosaminoglicanos/farmacocinética
2.
Semina Ci. agr. ; 42(05): 2959-2977, set.-out. 2021. ilus, tab, graf
Artículo en Inglés | VETINDEX | ID: vti-31838

RESUMEN

The study aimed to evaluate the in vitro antioxidant action of glycosaminoglycans (GAGs) from the skinof Oreochromis niloticus, and to determine their ideal concentration to supplement the sperm freezing medium of Prochilodus brevis. In experiment 1, the in vitro antioxidant properties of GAGs were verified through the analysis of DPPH, chelating ferrous ability, and total antioxidant capacity. In experiment 2, milt pools were formed, which were frozen in solution supplemented or not with different GAGs concentrations: 0 (control), 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, or 5.0 mg mL-¹ (total of 10 treatments). The samples were evaluated for membrane integrity, DNA integrity, sperm morphology, and sperm kinetics. The results of experiment 1 showed that the GAGs exhibited, with the increase of the concentration, significant antioxidant action, for all the evaluated tests, mainly in the chelating ferrous ability. In experiment 2, it was observed that the increase of GAGs concentration decreased kinetic parameters (P < 0.05), however, the control and 0.5 mg mL-1 GAGs concentration showed similar results. For the other parameters (membrane integrity, DNA integrity, and sperm morphology), there was no decrease in results with the increase of GAGs concentration. In conclusion, GAGs extracted from O. niloticus skin have antioxidant action, and the concentration of 0.5 mg mL-¹ was the most adequate to supplement the P. brevis sperm-freezing medium.(AU)


O estudo teve como objetivo avaliar in vitro a ação antioxidante de glicosaminoglicanos (GAGs) da pele de Oreochromis niloticus e determinar sua concentração ideal para suplementar o meio de congelação espermático de Prochilodus brevis. No experimento 1, foram verificadas as propriedades antioxidantes in vitro dos GAGs por meio das análises de DPPH, capacidade quelante do ferro e capacidade antioxidante total. No experimento 2, foram formados pool de sêmen, que foram congelados em solução suplementada, ou não, com diferentes concentrações de GAGs: 0 (controle); 0,5; 1,0; 1,5; 2,0; 2,5; 3,0; 3,5; 4,0; 4,5 ou5,0 mg mL-¹ (total de 10 tratamentos). As amostras foram avaliadas quanto à integridade da membrana, integridade do DNA, morfologia e cinética espermática. Os resultados do experimento 1, mostraram que os GAGs exibiram, com o aumento da concentração, ação antioxidante significativa, para todos os testes avaliados, principalmente na capacidade quelante do ferro. No experimento 2, observou-se que o aumento da concentração de GAGs diminuiu os parâmetros cinéticos (P < 0,05), porém o controle e a concentração de 0,5 mg mL-1 de GAGs apresentaram resultados semelhantes. Para os demais parâmetros (morfologia, integridade de membrana e de DNA), não houve diminuição dos resultados com o aumento da concentração de GAGs. Em conclusão, os GAGs, extraídos da pele de O. niloticus, possuem ação antioxidante, sendo a concentração de 0,5 mg mL-1 a mais adequada para suplementar o meio de congelação espermático de P. brevis.(AU)


Asunto(s)
Animales , Masculino , Criopreservación/métodos , Criopreservación/veterinaria , Antioxidantes/análisis , Characiformes/genética , Cíclidos/fisiología , Glicosaminoglicanos/análisis , Glicosaminoglicanos/farmacocinética
3.
Biochim Biophys Acta ; 1741(1-2): 30-41, 2005 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-15955447

RESUMEN

The aim of the present study was to further understand the changes in renal filtration that occur in the early stages of diabetes mellitus. Diabetes was induced in male Wistar rats by a single injection of streptozotocin. Glycemia, body weight, 24-h urine volume and urinary excretion of creatinine, protein and glycosaminoglycans were measured 10 and 30 days after diabetes induction. All the diabetic animals used in the present study were hyperglycemic, did not gain weight, and presented proteinuria and creatinine hyperfiltration. In contrast, the glycosaminoglycan excretion decreased. Dextran sulfates of different molecular weights (6.0 to 11.5 kDa) were administered to the diabetic rats, and to age-matched, sham-treated controls. Most of the dextran sulfate was excreted during the first 24 h, and the amounts excreted in the urine were inversely proportional to the dextran sulfate molecular weight for all groups. Nevertheless, diabetic rats excreted less and accumulated more dextran sulfate in kidney and liver, as compared to controls. These differences, which were observed only for the dextran sulfates of higher molecular weights (>7 kDa), increased with the duration of diabetes. Our findings suggest differential renal processing mechanisms for proteins and sulfated polysaccharides, with the possible involvement of kidney cells.


Asunto(s)
Diabetes Mellitus Experimental/orina , Glicosaminoglicanos/farmacocinética , Animales , Creatinina/orina , Sulfato de Dextran/administración & dosificación , Sulfato de Dextran/farmacocinética , Diabetes Mellitus Experimental/metabolismo , Tasa de Filtración Glomerular , Glicosaminoglicanos/sangre , Glicosaminoglicanos/orina , Masculino , Peso Molecular , Proteinuria , Ratas , Ratas Wistar , Factores de Tiempo , Distribución Tisular
4.
Biochim Biophys Acta ; 1335(1-2): 161-72, 1997 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-9133653

RESUMEN

Sulfated polysaccharides were administered to Wistar rats and their elimination from the blood as well as their urinary excretion were evaluated. Sulfated polysaccharides with differences in molecular mass, charge density and molecular structure were obtained from algae, marine invertebrates and vertebrates. A simple methodology based on the metachromatic property of these polysaccharides with 1,9-dimethylmethylene blue was used to estimate their concentration in urine and blood. Renal permselectivity to these macromolecules was based on molecular size, but the upper limit of molecular mass for excretion of a sulfated polysaccharide in urine varies among polymers with different structures. For dextran sulfates the upper limit is approximately 8 kDa. Chondroitin 4- and 6-sulfates were excreted as fragments of approximately 30 kDa, which is smaller than the injected polysaccharide. This suggests that they were degraded enzymatically in vivo. Large synthetic polymers (dextran sulfate > 8 kDa) were not excreted in urine, but slowly disappeared from the blood. Evaluation of their tissue distribution after intravenous administration indicated that these molecules are preferentially accumulated in the kidney.


Asunto(s)
Glicosaminoglicanos/farmacocinética , Animales , Sulfatos de Condroitina/farmacocinética , Sulfato de Dextran/farmacocinética , Galactanos/farmacocinética , Glicosaminoglicanos/sangre , Glicosaminoglicanos/orina , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Inyecciones Subcutáneas , Peso Molecular , Polisacáridos/farmacocinética , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA